Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure

September 10, 2026 · 10:17 pm 3 sources

Image: Yahoo Finance

Coverage

More coverage

• Novartis stock in hot water after another key failure
  Yahoo Finance · September 10, 2026 22:17
• Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
  Yahoo Finance · September 12, 2026 10:48
• Amgen (AMGN) Fell 5% on a Drug That Isn’t Even Its Own. Here’s the Lp(a) Bet Now in Question.
  Yahoo Finance · September 13, 2026 14:29